FC

Finepoint Capital Portfolio holdings

AUM $504M
This Quarter Return
-2.31%
1 Year Return
-3.16%
3 Year Return
+45.14%
5 Year Return
–
10 Year Return
–
AUM
$309M
AUM Growth
+$309M
Cap. Flow
+$18.1M
Cap. Flow %
5.85%
Top 10 Hldgs %
59.65%
Holding
61
New
4
Increased
8
Reduced
7
Closed
17

Top Buys

1
SRPT icon
Sarepta Therapeutics
SRPT
$17M
2
CRNX icon
Crinetics Pharmaceuticals
CRNX
$15.1M
3
RLAY icon
Relay Therapeutics
RLAY
$10.7M
4
SWTX
SpringWorks Therapeutics
SWTX
$8.71M
5
APLS icon
Apellis Pharmaceuticals
APLS
$3.56M

Top Sells

1
RCUS icon
Arcus Biosciences
RCUS
$16.9M
2
ARGX icon
argenx
ARGX
$10.2M
3
ISEE
IVERIC bio, Inc. Common Stock
ISEE
$5.99M
4
FOLD icon
Amicus Therapeutics
FOLD
$3.17M
5
ASTL icon
Algoma Steel
ASTL
$3.15M

Sector Composition

1 Healthcare 89.87%
2 Materials 6.6%
Name Market Value Portfolio Weight Shares or Principal Shares
Change % 		Capital Flow
TVTX icon
1
Travere Therapeutics
TVTX
$1.56B
$21.6M 6.98% 1,026,300 -2,575 -0.3% -$54.2K
ASTL icon
2
Algoma Steel
ASTL
$511M
$20.4M 6.6% 3,219,441 -497,291 -13% -$3.15M
PRTA icon
3
Prothena Corp
PRTA
$441M
$19.5M 6.29% 322,900 +17,500 +6% +$1.05M
ACAD icon
4
Acadia Pharmaceuticals
ACAD
$4.38B
$18.7M 6.06% 1,176,830 +65,800 +6% +$1.05M
CYTK icon
5
Cytokinetics
CYTK
$4.23B
$18.5M 5.97% 402,793 +22,000 +6% +$1.01M
FOLD icon
6
Amicus Therapeutics
FOLD
$2.34B
$17.4M 5.64% 1,428,475 -259,925 -15% -$3.17M
GLPG icon
7
Galapagos
GLPG
$2.07B
$17.3M 5.6% 390,359 +10,657 +3% +$473K
APLS icon
8
Apellis Pharmaceuticals
APLS
$3.48B
$17.3M 5.6% 334,890 +68,800 +26% +$3.56M
SRPT icon
9
Sarepta Therapeutics
SRPT
$1.78B
$17M 5.51% +131,457 New +$17M
SWTX
10
DELISTED
SpringWorks Therapeutics
SWTX
$16.7M 5.41% 643,000 +334,908 +109% +$8.71M
ASND icon
11
Ascendis Pharma
ASND
$11.8B
$16.4M 5.29% 134,036 +10,636 +9% +$1.3M
CERE
12
DELISTED
Cerevel Therapeutics Holdings, Inc. Common Stock
CERE
$16.3M 5.27% 517,287 -19,614 -4% -$619K
ISEE
13
DELISTED
IVERIC bio, Inc. Common Stock
ISEE
$15.2M 4.9% 707,600 -280,000 -28% -$5.99M
CRNX icon
14
Crinetics Pharmaceuticals
CRNX
$2.92B
$15.1M 4.87% +822,745 New +$15.1M
ARVN icon
15
Arvinas
ARVN
$568M
$14.7M 4.75% 429,600 +30,600 +8% +$1.05M
SAGE
16
DELISTED
Sage Therapeutics
SAGE
$14.6M 4.71% 381,765 -47,548 -11% -$1.81M
RLAY icon
17
Relay Therapeutics
RLAY
$619M
$10.7M 3.45% +714,848 New +$10.7M
IOVA icon
18
Iovance Biotherapeutics
IOVA
$807M
$9.88M 3.19% 1,545,589 -40,454 -3% -$258K
SLDB icon
19
Solid Biosciences
SLDB
$427M
$1.18M 0.38% +218,562 New +$1.18M
AAC.WS
20
DELISTED
Ares Acquisition Corporation Redeemable Warrants, each whole warrant exercisable for one Class A ordinary share at an exercise price of $11.50
AAC.WS
$235K 0.08% 504,706 – –
SMIHW
21
DELISTED
Summit Healthcare Acquisition Corp. Warrant
SMIHW
$139K 0.04% 489,999 – –
CORS.WS
22
DELISTED
Corsair Partnering Corporation Redeemable warrants, each whole warrant exercisable for one Class A ordinary share at an exercise price of $11.50
CORS.WS
$110K 0.04% 334,666 – –
BTWNW
23
DELISTED
Bridgetown Holdings Limited Warrants
BTWNW
$103K 0.03% 895,000 – –
CPAAW
24
DELISTED
Conyers Park III Acquisition Corp. Warrants
CPAAW
$85K 0.03% 571,666 – –
ZTAQW
25
DELISTED
Zimmer Energy Transition Acquisition Corp. Warrants
ZTAQW
$68K 0.02% 358,270 – –
1
2 3